CS

Chetan Sandhu

Active Director Director DIN 09062082
DIN 09062082 First appointment Feb 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 1 historical roles
Total affiliations 2 Since Feb 2021
Shareholding value •••• Premium profile

About Chetan Sandhu

Data last updated:

Chetan Sandhu is a Director at Synoscot Biotech Private Limited (since 2022). The companies operate in Trading and Pharma. Synoscot Biotech Private Limited reported revenue of ₹2.92 Cr (FY 2025). Earlier, Chetan Sandhu was a Director at Jaxrane Remedies Private Limited (2021–2022).

DIN 09062082
Primary Designation Director
Industry Trading
First Appointment 10 Feb 2021
Oldest Company Age 4 yrs
Largest company Synoscot Biotech Private Limited · ₹2.92 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Synoscot Biotech Private Limited U51909HR2022PTC102019
Director15 Mar 20222022₹2.92 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jaxrane Remedies Private Limited U24299HR2021PTC092839
Director10 Feb 20212021₹3.02 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Chetan Sandhu

NameDINCompanyDesignation
Jaspreet Singh09536519Synoscot Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Synoscot Biotech Private Limited
Jaxrane Remedies Private Limited
Premium access

Shareholding and investment profile for Chetan Sandhu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chetan Sandhu

Chetan Sandhu currently holds 1 directorship: Synoscot Biotech Private Limited (Director, since 15 Mar 2022, revenue ₹2.92 Cr (FY 2025)).

Chetan Sandhu was first appointed on 10 Feb 2021 as Director at Jaxrane Remedies Private Limited. The most recent appointment on record is 15 Mar 2022 at Synoscot Biotech Private Limited.

Chetan Sandhu held 1 earlier board appointment: Jaxrane Remedies Private Limited (Director, 10 Feb 2021 to 21 Feb 2022).

The current boards of Chetan Sandhu's companies include Jaspreet Singh (Synoscot Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available